Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

ACR 2016 Roundup: Remicade Copy Not So Similar; Mixed Sirukumab Results; Corbus’s Resunab Surge

Nov 16 2016

• By Mandy Jackson

microscope

Related Content

NOR-SWITCH Results ‘Concerning’ In Crohn’s Disease, Says Janssen

Nov 11 2016

Biosimilars Switching Debate Escalates After Remicade and Remsima Match In Landmark Study

Oct 20 2016

With Baricitinib, Lilly Hopes To Succeed Where Pfizer Has Struggled

May 30 2016

Keeping Track: Chugai Delivers Two Breakthroughs For Roche; FDA Continues To Wrestle With Opioid Regulation

Oct 07 2016

Amgen Bets $45m Plus Up To $1.7bn On Xencor's Bi-Specifics

Sep 16 2015

Case Studies: How Three Public Companies Financed R&D In A Tough Market

Jul 26 2016

Clever Marketing Needed To Position J&J's New Psoriasis Drug Ahead Of Cheaper Options

Oct 01 2016

Sanofi CEO Upbeat Despite Medivation M&A Miss, Sarilumab Diss

Oct 31 2016

Too Little, Too Late For GSK/Janssen's Sirukumab in RA?

Jun 13 2016

Video Interview: Corbus Sees 2016 As Pivotal Year

Feb 05 2016

PIPELINE WATCH: 19 Approvals, Nine Filings And One Launch

Oct 03 2016

A test for anti-TNF non-responders? Few alternative RA therapies available

Jul 30 2015

Related Companies

Johnson & Johnson

Johnson & Johnson

Celltrion, Inc.

GSK plc

Corbus Pharmaceuticals Holdings, Inc.

Xencor, Inc.

Roche Holding AG

Johnson & Johnson

AbbVie Inc.

Amgen, Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

Eli Lilly and Company

Incyte Corporation

Additional Topics

Research & Development Clinical Trials Inflammation Immune Disorders BioPharmaceutical

More from R&D

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window